SOL S.p.A. (BIT: SOL)
Materials · Chemicals · IT
€52.80
+0.38% today · +3.1% 1Y
SOL S.p.A. (BIT: SOL) operates in the Chemicals industry within the Materials sector. The company is valued at $5.59B and employs 7,100 people.
Over the last twelve months the share price has gained 3.1%, trading between 44.85 and 64.00.
Tweenvest scores SOL S.p.A. across four factors: quality 85/100, value 22/100, growth 61/100, dividend 76/100. Its strongest factor is quality.
SOL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.59B
- Revenue (TTM)
- $2.12B
- P/E
- 28.68
- EPS
- 1.84
- Dividend yield
- 0.86%
- Beta (5Y)
- 0.42
- 52-week high
- €64.00
- 52-week low
- €44.85
- Avg volume (3M)
- —
- Shares outstanding
- 90.70M
- Employees
- 7,100
- Next earnings
- —
About SOL S.p.A.
SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and medical gases, while simultaneously delivering comprehensive home healthcare solutions and associated medical equipment. Its extensive gas portfolio includes vital elements such as oxygen, nitrogen, and argon, alongside specialized gas mixtures, high-purity gases for the electronics industry, and food-grade gases. These products are supplied to various sectors including chemical, electronics, steel, metal, and food processing, as well as supporting environmental protection, scientific research, and healthcare. In the realm of home healthcare, SOL provides critical in-home therapies like oxygen, mechanical ventilation, and aerosol treatments. It also specializes in the diagnosis and management of respiratory sleep disorders, offers artificial nutrition programs, insulin pump therapy, immunotherapy, and dedicated support for pain and Parkinson's disease. Further extending its healthcare reach, the company delivers general home health and social care services, augmented by telemedicine platforms, digital health tools, and a range of healthcare aids. Beyond these core gas and home healthcare operations, SOL S.p.A. engages in a variety of complementary ventures. These encompass the design, construction, and management of biobanks; the generation and sale of hydroelectric power; and the provision of pre- and post-natal diagnostic screening. The company also develops and markets diagnostic systems and products for research and clinical applications across hospital, environmental, veterinary, and food sectors, alongside specialized bioshipping services for the secure transfer, storage, and handling of biological samples. Additional services include professional training, electromedical equipment support, hospital hygiene, environmental monitoring, and ambulance management, all facilitated by its proprietary InfoHealth SOLution web platform for operational oversight.
- ISIN
- IT0001206769
- Founded
- 1927
- Listed since
- Jul 17, 1998
- Exchange
- Borsa Italiana
- Currency
- EUR
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Linde plcNasdaqGS: LIN | $224.76B | $487.57 | +1.30% |
| L'Air Liquide S.A.ENXTPA: AI | $124.17B | €167.12 | -0.16% |
| The Sherwin-Williams CompanyNYSE: SHW | $83.64B | $346.59 | -0.09% |
| Ecolab Inc.NYSE: ECL | $78.95B | $281.63 | +0.05% |
| Shin-Etsu Chemical Co., Ltd.TSE: 4063 | $70.78B | ¥6,051.00 | -1.79% |
| Air Products and Chemicals, Inc.NYSE: APD | $67.94B | $305.10 | +1.59% |
| Corteva, Inc.NYSE: CTVA | $54.57B | $81.79 | +2.93% |
| BASF SEXTRA: BAS | $51.93B | €51.67 | +0.33% |
Figures last refreshed Aug 18, 2026.